In HLA-B27/Hu-β2m transgenic rats, MGF increased the time to onset of arthritis symptoms in a dose-dependent way, from 14 days in controls to 23 days at the high dose.
In plain wordsIn rats with induced arthritis, MGF delayed the start of arthritis symptoms in a dose-dependent way compared with the control group.
- Peptide
- MGF / PEG-MGF
- Outcome
- IncreaseTime to onset of arthritis symptoms
- Study
ratn: not reported in source
HLA-B27/Hu-β2m transgenic rats with induced arthritis and ankylosing spondylitis- Comparator
- Control group
- Outcome group
- Bone and joint · Musculoskeletal
- Studied dose
- Dose not stated · seven weeksAs given in this study (rat).
Measurements
- Time to onset
- 14 days
- control group
- Time to onset
- 23 days
- high-dose MGF
Source sentences
Our results indicated a dose-dependent increase in the time of onset of arthritis symptoms from 14 days in the control group to 23 days in the high-dose MGF group.
1 context sentence(design, population, supporting numbers)
HLA-B27/ Hu-β2m transgenic rats were inoculated with inactivated Mycobacterium tuberculosis to induce arthritis and ankylosing spondylitis, followed by MGF treatment for seven weeks.